Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKIP: Trulicity for Smoking Cessation
NCT03204396Phase 2Completed
- Sponsor
- University Hospital Basel
- Start
- Jun 2017
- Primary completion
- Jul 2022
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of dulaglutide in nicotine dependence, sponsored by University Hospital Basel. Started Jun 2017; status: completed.
02
Drugs
dulaglutide
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03204396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03204396.